1. Alkaline phosphatase ofhuman placenta was purified by a procedure involving homogenization with tris buffer, pH8-6, extraction with butanol, ammonium sulphate fractionation, exposure to heat, ethanol fractionation, gel filtration, triethylaminoethylcellulose anion-exchange chromatography, continuous curtain electrophoresis on paper and equilibrium dialysis. Methods for both laboratoryscale and large-scale preparation were devised. 2. Two major molecular-weight variants designated A and B were separated by molecular sieving with Sephadex G-200 and variant A was purified 4000-fold. 3. Variant B, which comes off the Sephadex G-200 column before variant A, is the electrophoretically slower-moving species on starch gel and is quite heterogeneous. 4. Purified variant A was fairly homogeneous on the basis of electrophoretic studies on starch gel and Sephadex gel, ultracentrifugation and imnmunodiffusion. 5. The respective molecular weights for variants A and B were 70000 and over 200 000 on the basis of sucrose-densitygradient ultracentrifugation. Variant A exhibited a sedimentation coefficient of 4-2s. 6. Crystalline variant B could be converted into fast-moving variant A and vice versa. 7. Kinetic studies indicated no difference between the two variants. These include linear rates of hydrolysis, pH optimum, Michaelis constants and uncompetitive stereospecific L-phenylalanine inhibition. 8. The amino acid compositions of variants A and B and of placental albumin were determined.
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One reason to undertake the purification of human placental alkaline phosphatase was the need to investigate with a homogeneous enzyme preparation the nature of the inhibition ofplacental alkaline phosphatase by L-phenylalanine (Fishman & Green, 1967) , an amino acid that had been recognized earlier as a stereospecific organ-specific inhibitor of the intestinal alkaline phosphatase of man (Fishman, Green &Inglis, 1963) and ofrat (Fishman, Green & Inglis, 1962; Ghosh & Fishman, 1966) .
Purification of human placental alkaline phosphatase (Anagnostopoulos & Matsudaira, 1957; Ahmed & King, 1960) occurred before the existence ofpolymorphic forms ofenzymes was widely known. Consequently, the products of purification were not homogeneous preparations.
The present investigation was therefore aimed at obtaining pure human placental alkaline phosphatase. Two species of enzyme were obtained that are indistinguishable enzymically, are both inhibited uncompetitively by L-phenylalanine, but differ in their molecular weights. A preliminary report of this work has been presented (Ghosh & Fishman, 1967 The tris buffer referred to below was 0-05M-tris-HCl solution, pH 8-6, in all experiments.
A88ay for alkaline pho8phata8e. The assay mixture (2ml.) contained 72mM-disodium phenyl phosphate in 50mM-Na2CO3-NaHCO3 buffer, pH 10-7, and 10mM-MgCl2. Enzyme solution (0-1 ml.) was added to the preheated (5min.) digest to initiate the reaction. The amount of phenol liberated in 15min. at 370 was measured by the method of Stolbach, Nisselbaum & Fishman (1958) as applied by us in earlier studies on intestinal alkaline phosphatase (Ghosh & Fishman, 1966; Fishman & Ghosh, 1967a) .
The unit of the enzyme is defined as that amount which liberates 1 tmole of phenol/ml./min. from 72mM-disodium phenyl phosphate containing lOmM-MgCl2 in 50mM-Na2CO3-NaHCO3 buffer, pH 10-7, at 37°. Mea8surement of protein. This was done by the microKjeldahl method, by the method of Lowry, Rosebrough, Farr & Randall (1951) or by measuring the extinction at 280m,u and at 260m,u in a Beckman model DU spectrophotometer.
Starch-gel electrophore8i8. This was carried out by the method of Smithies (1959) as modified in this Laboratory Fishman & Ghosh, 1967a) for 16hr. at 6 v/cm. at 4-6°.
Sucro8e-density-gradient centrifugation. The sucrosedensity-gradient centrifugation of the different purified specimens was carried out by applying 1 ml. of the diluted enzyme specimens to a 31 ml. linear sucrose gradient (5-20%, w/v) in tris-HCl buffer containing 1 mM-MgCI2. The reference standards for molecular weight were 14C_ labelled RNA at pH7-0, and bovine serum albumin and crystalline catalase at pH7-0 and pH8-3, and these were applied in a volume of 1 ml. to a companion sucrose gradient. After centrifugation of the gradients in a Beckman Spinco model L ultracentrifuge at 40 for 17hr. at 25000rev./min. in the no. SW25.1 rotor, 1ml. fractions were collected in graduated centrifuge tubes for assay.
The radioactivity of 14C-labelled RNA was measured in a Nuclear-Chicago mark I liquid-scintillation counter by using the channels-ratio counting technique.
Ultracentrifugal analysi8 of purified placental alkaline phosphatase (variant A) . The sedimentation velocity of the purified isoenzyme (variant A) of placental alkaline phosphatase was measured in a Beckman Spinco model E analytical ultracentrifuge with a double-sector quartz cell at 68°and a maximum speed of 59780rev./min. The protein concentrations were 3-8, 3-9 and 1-5mg./ml. The enzyme was dissolved in and dialysed against 0-M-tris-HCI buffer, pH 8-6. The photographs of the protein boundary of purified variant A were taken in the operating ultracentrifuge at 16min. intervals with a 700 diaphragm angle for the first photograph and 600 for the remainder, the exposure time being 2 see. in each case.
On one occasion the enzyme specimen was dissolved in 0-1M-veronal-HCl buffer, pH8-6, containing 0 5M-NaCl and dialysed against this buffer and then centrifuged as described.
The logarithm of the distance of the boundary from the axis of rotation was plotted against time. The slope of the straight line obtained was used in calculating the sedimentation coefficient, S, of the placental isoenzyme, the coefficient being determincd by applying the relation of Schachman (1957).
Immunochemical 8tudy. Ouchterlony double-diffusion tests of a number of preparations of human placental alkaline phosphatase obtained at different stages of purification were done in 1% agarose gel in 0 05M-veronal-HCl buffer, pH8-6, for 40hr. at room temperature. The preparation of the specific antibody against placental alkaline phosphatase was made by a modified method of Reif & Norris (1960) .
Amino acid compo8ition. The purified enzyme protein was treated with 6N-HCI, transferred to a Pyrex flask and the air was replaced by N2. After being sealed under vacuum, the tube was heated at 1140 for 20hr. Then the hydrolysate was evaporated to dryness in vacuo in a Ruchii Rotovapor to remove HCI and was analysed in the JLC-3BC amino acid analyser.
RESULTS
After a satisfactory procedure had been developed in the laboratory, it became evident that a largescale process was needed to prepare the enzyme in the desired quantity. Such a large-scale method was successfully devised. Both procedures are described as they differ in certain important respects.
Laboratory-8cale method of purification of placental alkaline pho8phatase The human placentas were collected at St Margaret's Hospital (Dorchester, Mass., U.S.A.) just after delivery and placed in the deep-freeze. All adherent blood clots were removed with a jet of cold water. The vascular mesoderm covering the foetal surface of the placenta and the umbilical cord were dissected away, the thoroughly washed placentas, each weighing 200-500g., becoming the starting material.
Step 1: preparation of the homogenate. Washed placenta was homogenized (500g.) in 4-51. of cold tris buffer, pH 86, in the Osterizer (John Oster Manufacturing Co., Milwaukee, Wis., U.S.A.) at top speed for 4 min. in batches of 50g. of placenta and 450ml. of tris buffer.
Step 2: butanol treatment. To the pooled homogenate (5000ml.) from step 1, 1975ml. of cold butanol (50) was added slowly while the mixture was being magnetically stirred at 5°. A total of 1 hr. stirring produced a stable emulsion, the temperature of which was then raised to and maintained at 370 for 10min. The thoroughly emulsified homogenate was poured into transparent 250ml. polycarbonate cups and then centrifuged in a Servall centrifuge (mojel RC-2) with rotor no. GSA Step 3: precipitation with ammonium sulphate. The dialysed butanol supernatant (51.) from step 2 cooled to 7°was treated with 31 10g. of solid enzymegrade ammonium sulphate and stirred vigorously for 30min., and the resulting precipitate was allowed to settle in the cold for 2hr. and spun in the Servall centrifuge at 35 0OOg for 30min. The solid r0sidue so obtained was dissolved in 500ml. of tris buffer, the supernatant being discarded.
Step 4: heat treatment. The enzyme solution (500ml.) in tris buffer (step 3) was transferred to a 11. flask, and this was immersed in a bath thermostatically maintained at 550 for 1 hr. with occasional agitation. The turbid solution was cooled in ice for 30min. and then was subjected to high-speed centrifugation (37 OOOg) for 20min. at 4°. The residue (suspended in tris buffer) exhibited a specific activity of 0-02 and was discarded. The supernatant was preserved for the next step. Two such supernatant preparations are required for the ammonium sulphate fractionation described in the next step.
Step 5: ammoniumn sulphate fractionation. The supernatant (600ml.) from step 4 was treated with 397 g. of solid ammonium sulphate and the resulting precipitate was collected by centrifugation as described in step 3 and was subjected to further fractionation as outlined in Scheme 1. The fractionation was done by extracting the solid precipitate with a variety of ammonium sulphate solutions of decreasing saturations. The enzyme in each fraction was recovered by raising the ammonium sulphate concentration of the mixture to a value at which these proteins become insoluble.
To justify the choice of this extraction rather than precipitation, the enzyme solution of step 4 prepared from a separate batch of 100g. of placenta was subjected to ammonium sulphate fractionation in the conventional method. That this 'extraction method' is more efficient than the 'precipitation method' is evident from Table 1 .
Each of the enzyme specimens was dialysed against tris buffer at 5-7°until free from ammonium ion as determined by Nessler's reagent. The complete removal of anmmonium sulphate (an inhibitor of alkaline phosphatase) by dialysis is mandatory before the next step.
Step 6 the highest enzyme activity and was dissolved in water for the following step.
Step 7: Sephadex-G-200-gel filtration. Sephadex G-200 (particle size 40-120,u) was allowed to swell in tris buffer, pH 8-6, at 5-7°. The buffer was changed at 16hr. intervals for 5 days to remove the lighter particles by decantation. The gel was poured as a thin slurry into a closed vertical column The precipitation method involved precipitation of enzyme protein with increasing concentrations of (NH4)2S04, starting with the lowest one. The fractionation method was initiated from the highest concentration of (NH4)2SO4, the details of the procedure being outlined in Scheme 1.
Conen. of (NH4)2SO4 (%saturation) (60cm. x 2.5cm.) and was then allowed to settle to 25% of the desired column height. Next, additional Sephadex slurry was added until the desired bed height was obtained with the drain outlet open. Finally, the bed was washed for at least 24hr. with tris buffer in the cold (4-5°), to ensure the equilibrium and stabilization of the column height. Fraction no. 
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The enzyme solution was layered dropwise on the top of the column over 5hr. by a siphon arrangement from a reservoir and then was eluted with the same tris buffer with a well-controlled gravity flow. Fractions (20ml.) were monitored for protein and enzyme activity. Starch-gel-electrophoresis patterns of eluates from a typical filtration indicate slow-moving (B) and fast-moving (A) variants of human placental alkaline phosphatase. The separation of variants A and B is more efficient with the larger column (Fig. 1) .
Variant A contains appreciable amounts of placental albumin, wvhich can be removed by either step 8 (TEAE-cellulose anion-exchange chromatography) or step 9 (continuous paper curtain electrophoresis) or by both steps.
Step 8: TEAE-cellulose anion-exchange chromatography. The best enzyme samples from step 7 were concentrated and dialysed against eluting buffer. The concentrated enzyme solution was applied dropwise on the top of a TEAE-cellulose column (2cm. gradient elution was performed with 500ml. of tris buffer in the mixing chamber and 500ml. of 50mM-magnesium chloride in tris buffer in the reservoir flask. Fractions (3ml.) were collected every 20min. in the Technicon automatic fraction collector. The extinction at 280mu and enzyme activity of each of the fractions were determined and the values are plotted in Fig. 2 .
Step 9: continuous curtain electrophoresis. This was carried out in a B3eckman Spinco model CP unit at 4-5°in the presence of 20mM-veronalhydrochloric acid buffer, pH8-6, with a current of 70mA at 800v (constant voltage). The enzyme sample was first concentrated to one-third volume in a cellophan bag covered with dry Sephadex G-200 at 4-5°for 48hr. or more and then equilibrated by dialysing against 20mM-veronal buffer, pH8 6, overnight at 40.
The paper curtain was equilibrated with buffer until smooth vertical movement of the protein dye spots was obtained. The speed of the sample delivery was regulated to 3-4ml./hr. and fractions were collected automatically in a Beckman Spinco model CPF fraction collector at 12hr. intervals starting from the time of first appearance of protein at the drip points (usually 6hr. after the feeding of the sample) until about 12hr. after the enzyme solution had been completely introduced into the system. All tubes were assayed for alkaline phosphatase activity, and protein and the total activity for each tube were computed.
After completion of the run, the position of protein remaining on the paper was ascertained as follows. The paper was dried at 1000 for 30min., washed with methanol and stained for 1 hr. with methanolic 0.1% bromophenol blue solution, washed four to six times with 5% (v/v) acetic acid and dried again at 100°. The stained areas on the paper of a typical run are shown in Fig. 3 . The values for total enzyme activity and the protein concentration per tube are plotted against the corresponding fraction numbers, which are shown to originate from the stained areas of the paper.
In another experiment, each of the 32 fractions obtained by continuous curtain electrophoresis was subjected to starch-gel electrophoresis. The starchgel-electrophoresis patterns of protein of the fractions and a typical zymogram showing the enzyme protein band (variant A) are presented in Fig. 4 along with the curtain-electrophoresis curves for enzyme activity and protein concentration.
The results presented in Figs. 3 and 4 indicate the presence of enzyme in fractions 9-17, whereas fractions 22-32 contained very little enzyme but considerable amounts of albumin.
Variant B purified by Sephadex-gel filtration could be subjected to continuous curtain electrophoresis in the same manner as variant A. Step 10: conversion of variant A into a crystalline product by equilibrium dialy8i8. The enzyme specimens (variant A or a mixture of variants A and B) of highest specific activity in the previous step were precipitated with ethanol and dissolved in a minimum volume of 0.1 M-magnesium chloride and dialysed. The dialysis of this enzyme solution, which exhibited a conductance ofabout 8600,umhos, was carried out in cellophan tubing in a selfagitating Oxford multiple dialyser (model B) (from Arthur H. Thomas Co., Philadelphia, Pa., U.S.A.) constructed according to the design of Durrum, Smith & Jetton (1954) . The sample was rotated electrically in the dialysing bath at constant rate of 10rev./min. for 2-5 days at 5-7°against 400vol. of a solution of pH near 5-6 containing 2 mM-potassium chloride and 1 mM-magnesium chloride (conductance 200 ,tmhos). The initial pH7-0 of the enzyme specimen slowly changed to pH 5 6 at the end when the equilibrium was reached. The dialysis was continued until the conductance of the enzyme solution inside the cellophan bag and of the outside solution both were about 300 ,umhos. Crystals with characteristic 'silky shimmer' appeared after 1-2 days of dialysis but completion of the crystallization required several weeks. After removal of the first crop of crystals the supernatant was subjected again to the same method of dialysis as described above after the ; I Vol. 108 HUMAN PLACENTAL ALKALINE PHOSPHATASE VARIANTS addition of seed crystals. On microscopic examination the crystals appeared as colourless hexagonal prisms capped by pyramids (Fig. 5) . The crystals, which were insoluble in distilled water at 20 25°a nd sparingly soluble in buffer, were washed with water five or six times to remove adhering impurities and were reconstituted in 50mM-magnesium acetate. Crystalline variant B exhibited an activity of nearly 400 units/mg. of protein. Starch-gel electrophoresis of the crystalline enzyme specimen prepared by this method demonstrated only one broad enzyme band near the origin (Fig. 8) .
Large-8cale procedure
The equipment and facilities of the Tufts Enzyme Center were employed and the direction followed was that of the laboratory-scale purification except that it was necessary to simplify the extraction of the enzyme from the ammonium sulphate precipitate and to omit the ethanol step.
All operations described in steps 1-3 were carried out at 5-7°.
Step 1: preparation of the homogenate. Washed placentas (18kg.) were ground in an electrical meat grinder and then were introduced, 500g. at a time, into a precooled Gifford-Wood colloid mill to make the 10% homogenate with 1701. of tris buffer, pH8 6, homogenization being carried out for 4min. The homogenate (approx. 1801.) was then put in a glass-lined thermostatically controlled tank (3001. capacity). Cold butanol (1 121.) was then added in a slow stream while the whole mixture was mechanically agitated and the stirring was continued for lhr. After thorough emulsification of the tissuebutanol mixture, the temperature of the tank was increased to 370 and maintained at that temperature for 10min. and then cooled to 4°.
Step 2: preparation of the butanol 8upernatant. at 5-7°.
Step 3: precipitation and fractionation with ammoniUM 8uIphate. The butanol supernatant (57 1.) from step 2 was treated and stirred with 37-7kg. of solid enzyme-grade ammonium sulphate in a 3001. tank. The powdered ammonium sulphate was added slowly while the mixture was stirred vigorously and the stirring was continued for another 30min. The mixture was kept at 5-7°for lhr., whereupon the enzyme precipitate rose to the top. The aqueous layer (651.) was drained out through the outlet at the bottom. The remaining mixture (271.) was either centrifuged in the Sharples supercentrifuge at 60 OOOg or filtered through a Buchner funnel under vacuum.
The residue obtained was stored at 5-7°until it could be subjected to a simplified fractionation procedure outlined in Scheme 2.
Step 4: eXposure to heat. The three enzyme solutions (i), (ii) and (iii) from step 3 (Scheme 2)
were each heated at 550 for 60min. and cooled in an ice bath to 4°. They were centrifuged, the precipitates were discarded and the three supernatants dialysed overnight against 1501. of tris buffer, pH 8 6, and then centrifuged again.
Step5:Sephadex-G-200-gelfiltration. Gelfiltration was carried out in a 100 cm. x 10 cm. vertical column after freeze-concentration of specimens (ii) and (iii) of step 4 to nearly one-quarter of their original volume. The elution profile for the gel filtration of specimen (ii) is presented (Fig. 1) . During molecular sieving of the enzyme two distinct pigmented protein bands could be seen inside the column. From the lower zone, one variant form of alkaline phosphatase appeared (variant B); variant A was eluted later with a larger volume of the eluent (upper zone). Thus variant B is a heavier molecular species than variant A.
The three remaining steps are conducted as outlined under the description of the laboratoryscale method for steps 8, 9 and 10.
The typical protocols of purification by the laboratory-scale and large-scale methods are presented in Tables 2 and 3 respectively.-An analysis of the two fractionations indicates that a major loss recurred during large-scale purification in the activity of the 60-90%-and 30-60%-saturated ammonium sulphate fractions; this may now reasonably be attributed to the denaturation produced by employing the large-scale heavy-duty mixers.
Physical properties of molecular variants A and B of placental alkaline phosphatase Sucrose-density-gradient centrifugation. The rates of centrifugation of variants A and B of placental alkaline phosphatase were compared in Fig. 6 with those of three standard markers, crystalline bovine serum albumin, 4s, 16s and 23s 14C- RNA samples and crystalline bovine liver catalase. The alkaline phosphatase activities were measured in the fractions; the bovine serum albumin was determined spectrophotometrically by recording the extinction at 280m,u and the catalase was assayed by noting the rate of diminution of the extinction at 240m,u (AE240/min.) in the Beckman Spinco DK-1 automatic recording spectrophotometer with hydrogen peroxide as the substrate at pH7-1 (50mM-phosphate buffer). Molecular variant B is more rapidly sedimented than variant A, which, in turn, sediments like bovine serum albumin. Variants A and B are found to have molecular weights of 70000 and > 200000 respectively when these sedimentation data are computed according to the method of Martin & Ames (1961) .
The sucrose-density-gradient centrifugation profile (Fig. 6) indicates that variant B of placental alkaline phosphatase exists as a heterogeneous mixture of the heavier forms of placental alkaline phosphatase.
Starch-gel zymograms ofthe alkaline phosphatase fractions in the less-dense region of the sucrose density gradient showed a fast-moving zone in contrast with the slow-moving zone from fractions representing the more-dense region of the sucrose density gradient.
Ultracentrifugation. Fig. 7(b) shows the ultracentrifugal pattern of purified molecular variant A in OlM-veronal buffer, pH86, taken 73min. after attaining 59 780rev./min. with the phase-plate angle 50°. Fig. 7(a) illustrates the results obtained in O lM-tris buffer, pH8*6, 128min. after attaining 786 1968 Vol. 108 HUMAN PLACENTAL ALKALINE PHOSPHATASE VARIANTS Table 2 . Purification of human placental alkaline pho8phata8e by the laboratory-8cale method The values given for steps 5, 6 and 7 represent the fractions of highest specific activity selected for the next step of the purification.
Step 8 (TEAE-cellulose anion-exchange chromatography) is illustrated in Fig. 2 Table 3 . Purification of human placental alkaline phosphatase variants A and B by the large-scale method
The values given for steps 5, 6 and 7 represent the fractions of highest specific activity selected for the next step of the purification. Steps 6, 7 and 8 correspond respectively to steps 8, 9 and 10 of the laboratory-scale method. Starch-gel and Sephadex-gel electrophoresis.
Starch-gel electrophoresis ) of purified variant A showed one protein band, at the same location as the single enzyme band; albumin was absent. When the same specimen was subjected to Sephadex-G-200-gel electrophoresis convert molecular variant A into crystalline variant B (Fig. 5) . The starch-gel-electrophoretic patterns of variant A and of variant B obtained by crystallization (Fig. 8) show that fast-moving variant A becomes variant B. Crystalline variant B of placental alkaline phosphatase when kept in 50mM-carbonate-bicarbonate buffer, pH 9-2, at 5-6o for about 4 months showed the formation of electrophoretically fast-moving variant A. These results were corroborated by ultracentrifugal studies, which indicated that the supernatant of variant B after long storage contained the electrophoretically fast-moving variant A with its characteristic sedimentation peak of 4 s enzyme protein. The comparatively low electrophoretic mobility of variant B can likewise be explained by the heavier mass of the molecular aggregate.
Immunodiffu8ion. Immunodiffusion patterns of purified placental alkaline phosphatase at different steps of purification are presented in Fig. 9 . The final purified product of variant A gave rise to a single precipitin line that fused completely with one line of the other preparations. Variant A thus shows immunochemical homogeneity.
Chemical compo8ition
0 Amino acid compo8ition. Table 4 summarizes the results of amino acid analyses of purified variants A and B of human placental alkaline phosphatase. These results are compared with the analyses of pure placental albumin, a by-product during curtain electrophoresis of placental alkaline phosphatase preparations. Lysine, serine and cysteine residues, all of which are implicated in the mechanism of cataly3is (Fishman & Ghosh, 1967a,b) , aro (Beaven & Holiday, 1952) and hexosamine by amino acid analysis with ninhydrin and also by the method of Yoshizawa (1961) .
Amino acid residues (moles/70000g. of protein)
Placental alkaline identical (18mmm at pH 10-6). The two variants have optimum pH106 and 10-7 with 18mM-and 72mM-phenyl phosphate respectively. A typical plot (Fig. 11) shows enzyme (variant A) activity as a function of pH at 72mm substrate concentration. Fig. 12 illustrates that the optimum pH of is expressed as utmoles of phenol Iiberated/ml./min. at 37°. 50mm-Na2CO3-NaHCO3 buffer was used.
equivalent concentration of L-phenylalanine. Previous papers (Ghosh & Fishman, 1966; Fishman & Ghosh, 1967a) record similar shifts in optimum pH for rat and human intestinal alkaline phosphatases. L-Phenylalanine inhibition of cry8talline placental alkaline pho8phataae (variant B) as function of phenyl pho8phate concentration. The extent of L-phenylalanine inhibition of crystalline variant B was determined at various phenyl phosphate concentrations (0.9-27mm) and the results showed that the inhibition was dependent on substrate as Fig. 13 and suggest that the inhibition is 'uncompetitive', as the reciprocal plots in the presence of L-phenylalanine are straight lines parallel to the one obtained in the presence of the equivalent concentration of the non-inhibitory D-phenylalanine, as with the rat (Ghosh & Fishman, 1966) and human (Fishman & Ghosh, 1967a) intestinal alkaline phosphatases. The extent of L-phenylalanine inhibition of human placental alkaline phosphatase was dependent on pH (Fig. 14) , exhibiting optimum inhibition at pH9-6.
Variants A and B of placental alkaline phosphatase are kinetically indistinguishable from each other. Some of the kinetic parameters of the isoenzyme variants are listed in Table 5 .
DISCUSSION
A homogeneous preparation of placental alkaline phosphatase for studies of L-phenylalanine inhibition has been achieved and led to the discovery of forms with different molecular weights. As with the intestinal enzyme reported by Ghosh & Fishman (1966) a type of pH-and substrate-dependent ' uncompetitive' inhibition was observed. Uncompetitive inhibition of intestinal and placental isoenzymes by L-phenylalanine is discussed by Fishman & Ghosh (1967a) .
With regard to the purification process itself, the following features are of interest. The enzyme is firmly associated with membranes from which it can be released by butanol treatment. The thermal stability of the enzyme is a property that has been exploited to inactivate contaminating phosphatases and other enzymes. Placental albumin presented the most tenacious contaminant ofthe final preparations, from which it could be removed completely by TEAE-cellulose chromatography and by preparative paper curtain electrophoresis. The laboratory-scale and the large-scale purification methods have been tested with more than 15 batches of placenta and the purification has been found to be reproducible. The specific activity of the final product of variant A was 4000-fold that of the starting material and possessed the highest specific activity recorded so far for this enzyme. The crystalline product prepared by equilibrium dialysis (Liss, 1965; Yonetani, Chance & Kajiwara, 1966) was only slightly soluble in aqueous buffered solutions. Its lower specific activity is not unexpected on the basis of other reports (Womack & Colowick, 1967; Nyman, 1961; Rickli & Edsall, 1962) and the formation of crystalline enzyme with unusually low solubility and decreased specific activity has been noted by Stormer (1967) .
The weight of experimental evidence supports the view that human placental alkaline phosphatase exists in variants that can be distinguished by their molecular weights. Physical methods that have successfully separated these forms include starch-gel and Sephadex-gel electrophoresis, gel filtration and sucrose-density-gradient centrifugation. Moreover, the analytical-ultracentrifuge data indicate that the lighter form has a molecular weight of 70 000. The heavier forms have molecular weights above 200000 (sucrose-density-gradient centrifugation), and these two categories are now termed molecular-weight variants A and B respectively.
These two variants are interconvertible. Equilibrium dialysis yields a crystalline product that results from the association of enzyme proteins of low molecular weight (Craig, Chen & Printz, 1967) . It travels as a slow-moving band on starch-gel electrophoresis. The crystalline material undergoes gradual disaggregation, yielding the lighter variant A as shown by ultracentrifugal and electrophoretic studies.
Variants A and B have very similar amino acid compositions except for the larger number of ammonia-forming amino acid residues in variant B.
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The difference between the combined weight of the amino acids plus hexosamines and the molecular weight of 70000 is duo to sialic acid (Ghosh, Goldman & Fishman, 1967) 
